Thiamin(e): The spark of life

Subcellular Biochemistry

Volumn 56, Issue , 2015, Pages 199-227

  Lonsdale, Derrick ^a  

^a Preventive Medicine Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84930192941     PISSN: 03060225     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-94-007-2199-9_11     Document Type: Article

References (115)

1. Adamolekum B, Ndububa DA (1994) Epidemiology and clinical presentation of a seasonal ataxia in Western Nigeria. J neurol Sci 124(1):95–98
2. Bannister R (ed) (1984) Autonomic failure: a textbook of clinical disorders of the autonomic nervous system, 2nd edn. Oxford University Press
3. Barker JN, Jordan F (1982) Phrenic thiamin and neuropathy in sudden infant deaths. In: Sable HZ, Gubler CJ (eds) Thiamin: twenty years of progress. Ann N Y Acad Sci 378: 449–452
4. Beltramo E, Berrone E, Buttiglieri S, Porta M (2004) Thiamine and benfotiamine prevent increased apoptaosis in endothelial cells and pericytes cultured in high glucose. Diabetes Metab Res Rev 20(4):330–336
5. Bettendorff L, Michel-Cahay C, Grandfils C, DeRycker C, Schoffeniels E (1987) Thiamine triphosphate and membrane-associated thiamine phosphatases in the electric organ of Electophorus electricus. J Neurochem 49:495–502
6. Bettendorff L, Kolb HA, Schoffeniels E (1993) Thiamine triphosphate activates anion channels of large unit conduction in neuroblastoma cells. J Membr Biol 136:281–288
7. Bettendorff L, Hennuy B, De Cherek A, Wins P (1994) Chloride permeability of rat brain vesicles correlates with thiamine trophosphate content. Brain Res 652:157–160
8. Bhuvaneswaran C, Sreenivaran A (1962) Problems of thiamine deficiency states and their amelioration. Ann N Y Acad Sci 98:576–601
9. Bitsch R, Wolf M, Moller J et al (1991) Bioavailability assessment of the lipophilic benfotiamine as compared to a water-soluble thiamine derivative. Ann Nutr Metab 35:292–296
10. Blass J (1972) Abnormalities in pyruvate dehydrogenase and neurologic function. Intern J Neruosci 4:65–69
11. Blass JP, Gibson GE (1977) Abnormality of a thiamine requiring enzyme in patients with Wernicke-Korsakoff syndrome. N Engl J Med 297:1367–1370
12. Blass JP, Gleason P, Brush D, DiPonte P, Thaler H (1988) Thiamine and Alzheimer’s disease. Arch Neurol 45:833–835
13. Boni L, Kieckens L, Hendricx A (1980) An evaluation of a modified erythrocyte transketolase assay for assessing thiamine nutritional adequacy. J Nutr Sci Vitaminol 26:507–514
14. Brin M (1964) The antithiamine effects of amprolium in rats on tissue transketolase activity. Toxicol Appl Pharmacol 6:454–458
15. Caddell JL (1972) Magnesium deprivation in sudden unexpected infant death. Lancet ii 258–262
16. Cooper JR, Pincus JH (1979) The role of thiamine in nervous tissue. Neurochem Res 4:223–239
17. Cooper JR, Itokawa Y, Pincus JH (1969) Thiamine triphosphate deficiency in subacute necrotizing encephalomyelopathy. Science 164:72–73
18. Cooper JR, Pincus JH, Itokawa Y, Piros K (1970) Experiences with phosphoribosyl transferase inhibition in subacute necrotizing encephalomyelopathy. N Engl J Med 283:793–795
19. Dancis J, Hutzler J, Rokkones T (1967) Intermittent branched chain ketonuria: Variant of maple-syrup-urine disease. New Engl J Med 276:84–89
20. Djoenaidi W, Notermans SL (1990) Thiamine tetrahydrofurfuryl disulfide in nutritional polyneuropathy. Eur Arch Psychiatry Neurol Sci 239:218–220
21. Djoenaidi W, Notermans SL, Dunda G (1992) Beriberi caardiomyopathy Eur J Clin Nutr 46:227–234
22. Duran M, Tielens AGM, Wadman SK et al (1978) Effects of thiamine in a patient with a variant form of branched-chain ketoaciduria. Acta Paediatr Scand 67:367–372
23. Dyckner T, Elk B, Nyhlin H, Wester PO (1985) Aggravation of thiamine deficiency by magnesium depletion. A case report. Acta Scand 218:129–131
24. Edwin EE, Jackman R (1970) Thiaminase I in the development of cerebrocortical necrosis in sheep and cattle. Nature 228(5273):772–774
25. Eisinger J, Bagneres D, Arroyo P, Plantamura A, Ayavou T (1994) Effect of magnesium, high energy phophates, piracetam and thiamin on erythrocyte transketolase. Magnes Res 7:59–61
26. Elmadfa I, Majchrzak D, Rust P, Genser D (2001) The thiamine status of adult humans depend on carbohydrate intake. Int J Vitam Nutr Res 71:217–221
27. Elsas LJ, Danner DJ (1982) The role of thiamin in maple syrup urine disease. In: Sable LJ, Gubler CJ (eds) Thiamin: twenty years of progress. Ann N Y Acad Sci 378: 404–420
28. Fehily L (1944) Human milk intoxication due to B1 avitaminosis. Br Med J 2:590–592
29. Frank T, Bitsch R, Malwaki J, Stein G (1999) Alteration of thiamine phramacokinetics by end-stage renal disease (ESRD). Int J Clin Pharmacol Ther 37:449–455
30. Fujita A (1954) Thiaminase. In: Nord FF (ed) Advances in enzymology, vol 15—. Interscience Publishers, pp 389–421
31. Fujita T, Suzuoki Z (1973a) Enzymatic studies on the metabolism of the tetrahydrofurfuryl mercaptan moiety of thiamine tetrahydrofurfuryl disulfide. I Microsomal S-transmethylase. J Biochem 74:717–722
32. Fujita T, Suzuoki Z (1973b) Enzymatic studies on the metabolism of the tetrahydrofurfuryl mercaptan moiety of thiamine tetrahydrofurfuryl disulfide. III Oxidative cleavage of the tetrahydrofuran moiety. J Biochem 74:733–738
33. Fujita T, Suzuoki Z, Kozuka S (1973a) Enzymatic studies on the metabolism of the tetrahydrofurfuryl mercaptan moiety of thiamine tetrahydrofurfuryl disulfide. II Sulfide and sulfoxide oxygenases in microsomes. J Biochem 74:723–732
34. Fujita T, Teraoka A, Suzuoki Z (1973b) Enzymatic studies on the metabolism of the tetrahydrofurfuryl mercaptan moiety of thiamine tetrahydrofurfuryl disulfide. IV Induction of microsomal S-transmethylase and sulfide and sulfoxide oxygenases in the drug-treated rat. J Biochem 74:739–745
35. Fujiwara M (1965) Absorption, excretion and fate of thiamine and its derivatives in [the] human body. In: Shimazono N, Katsura E (eds) Thiamine and Beriberi. Igaku Shoin Ltd, Tokyo, pp 179–213
36. Ganapathy V, Smith SB, Prasad PD (2004) SLC19: the folate/thiamine transporter family. Pflugers Arch 447:641–646
37. Gibson GE, Barclay L, Blass J (1982) The role of the cholinergic system in thiamin deficiency. In: Sable HZ, Gubler CJ (eds) Thiamin: twenty years of progress. Ann N Y Acad Sci 378: 382–403
38. Gibson GE, Zhang H (2002) Interactions of oxidative stress with thiamine homeostasis promote neurodegeneration. Neurochem Int 40:493–504
39. Gray GE (1987) Crime and diet: Is there a relationship? Wld Rev Nutr Diet 49:66–86
40. Harada H, Rikimaru F, Mori T, Tanaka ME et al (2002) Electroencephalographic changes during intravenous olfactory stimulation in humans. Clin Electroencephalogr 33:189–192
41. Haupt E, Ledermann H, Kopcke W (2005) Benfotiamine in the treatment of diabetic polyneuropathy—a three–week randomized, controlled pilot study (BEDIP study) Int J Clin Pharmacol Ther 2005;43:71–77. Erratum in: Int J Clin Pharmacol Ther 2005;43:304
42. Henderson GI, Schenker S (1975) Reversible impairment of cerebral DNA synthesis in thiamine deficiency. J Lab Clin Med 86:77–90
43. Inouye K, Katsura E (1965) Etiology and pathology of beriberi. In: Thiamine and Beriberi. Igaku Shoin Ltd., Tokyo, pp 1–28
44. Iwata H, Nishikawa T, Fujimoto S (1969a) Monoamine oxidase activities in tissues of thiamine-deficient rats. J Pharm Pharmac 21:237–240
45. Iwata H, Watanabe K, Nishikawa T, Ohashi M (1969b) Effects of drugs on behavior, heart rate and catecholamine levels in thiamine-deficient rats. Eur J Pharmacol 6:83–89
46. Iwata H, Yabushita Y, Doi T, Matsuda T (1985) Synthesis of thiamine triphosphate in rat brain in vivo. Neurochem Res 10:779–787
47. Jansen BCT, Donath WF (1926) On the isolation of the anti-beriberi vitamin. Proc I Acad Wei Amsterdam 29:1390
48. Jeffrey HE, McCleary BV, Hensley WJ, Read DJC (1985) Thiamine deficiency- a neglected problem of infants and mothers- possible relationship to sudden infant death syndrome. Aust NZ J Obst Gynaecol 25:198–202
49. Jeyasingham MD, Pratt O, Burns A, Shaw GK, Thompson A, Marsh A (1987) The activation of red blood cell transketolase in groups of patients especially at risk from thiamin deficiency. Psych Med 117:311–318
50. Kikuchi S, Nishikawa K, Suzuoki Z (1970) The metabolism of thiamine thetrhydrofurfuryl disulfide in the rat, rabbit and man. Eur J Pharmacol 9:367–373
51. Kimura M, Itokawa Y (1977) Effects of calcium and magnesium deficiency on thiamine distribution in rat brain and liver. J Neurochem 28:389–393
52. Lagarde WH, Underwood LE, Moats-Staats BM, Calikoglu AS (2004) Novel mutation in the SLC19A2 gene in an African-American female with thiamine-responsive megaloblastic anemia syndrome. Am J Med Genet 125:299–305
53. Lesch M, Nyhan WL (1964) A familial disorder of uric acid metabolism and central nervous system function. Am J Med 36:561–570
54. Loew FM (1974) Possible animal model of subacute necrotizing (Leigh’s) encephalomyelopathy J Pediat 85:876–877
55. Lonsdale D (1975) Thiamine metabolism in disease. Crit Rev Lab Sci 5:289–313
56. Lonsdale D (1977) Treatment of threatened SIDS with megadose thiamine hydrochloride. Pediat Res 11:379 (Abstr)
57. Lonsdale D (1978) Wernicke’s encephalopathy and hyperalimentation. JAMA 239:1133. (Letter to the editor)
58. Lonsdale D (1980) Recurrent febrile lymphadenopathy treated with large doses of vitamin B1: Report of two cases. Dev Pharmacol Ther 1:254–264
59. Lonsdale D (1981) The syndrome of functional dysautonomia. Med Hypoth 7:495–502
60. Lonsdale D (1982) Effect of thiamine tetrahydrofurfuryl disulfide on audiogenic seizures in DBA/J2 mice. Dev Pharmacol Ther 4:28–36
61. Lonsdale D (1987a) A nutritionist’s guide to the clinical use of vitamin B1. Life Sciences Press, Tacoma, pp. 5–12
62. Lonsdale D (1987b) Biochemical studies in functional dysautonomia. In: A nutritionist’s guide to the clinical use of vitamin B1. Life Sciences Press, Tacoma, WA, pp. 78–115
63. Lonsdale D (1990a) Hypothesis and case reports: possible thiamin deficiency. J Am Coll Nutr 9:13–17
64. Lonsdale D (1990b) Asymmetric functional dysautonomia. J Nutr Med 1:59–61
65. Lonsdale D (1990c) Thiamine deficiency and sudden deaths. Lancet ii:376
66. Lonsdale D (1992a) Criminal behavior and nutrition. J Adv Med 5(2):494–504
67. Lonsdale D (1992b) Criminal behavior and nutrition. J Adv Med 5:115–123
68. Lonsdale D (1994a) Crime and violence: A hypothetical explanation of its relationship with high calorie malnutrition. J Adv Med 7(3):171–180
69. Lonsdale D (1994b) The three circles of health. In: Why I left orthodox medicine. Hampton Roads Publishing Company, Charlottesville, pp 189–207
70. Lonsdale D (2001a) Nutritional therapy in children with functional disorders of activity, behavior, attention and learning. Clin Pract Altern Med 2:196–203
71. Lonsdale D (2001b) Sudden infant death syndrome requires genetic predisposition, some form of stress and marginal malnutrition. Med Hypoth 57:382–386
72. Lonsdale D. (2006a) http://www.soilandhealth.org/02/0201hyglibcat/0201hyglibcat.html
73. Lonsdale D (2006b) A review of the biochemistry, metabolism and clinical benefits of thiamin(e) and its derivatives. eCAM 3(1):49–59
74. Lonsdale D (2006c) Three case reports to illustrate clinical applications in the use of transketolase. eCAM 4(2):247–250
75. Lonsdale D, Kissling CD (1987) Clinical trials with thiamine tetrahydrofurfuryl disulfide in Down’s syndrome. J Orthomolecular Med 1:169–175
76. Lonsdale D, Mercer RD (1972) Primary hypoventilation syndrome. Lancet ii:487 (Letter to the editor)
77. Lonsdale D, Price JW (1973) Pyruvic aciduria in the detection of thiamine responsive encephalopathy. Cleve Clin Quart 40:79–88
78. Lonsdale D, Shamberger RJ (1980) Red cell transketolase as an indicator of nutritional deficiency. Am J Clinc Nutr 33:205–211
79. Lonsdale D, Faulkner WR, Price JW, Smeby RR (1969) Intermittent cerebellar ataxia associated with hyperpypruvic academia, hyperalaninemia, and hyperalaninuria. Pediatrics 43:1025–1034
80. Lonsdale D, Nodar RH, Orlowski JP (1979) The effects of thiamine on abnormal brainstem auditory evoked potentials. Cleve Clin Quart 46:83–88
81. Lonsdale D, Nodar RH, Orlowski JP (1982) Brainstem dysfunction in infants reaponsive to thiamine disulfide; preliminary studies in four patients. Clin EEG 13:82–88
82. Lonsdale D, Shamberger RJ, Audhya T (2002) Treatment of autistic spectrum children with thiamine tetrahydrofurfuryl disulfide: a pilot study. Neuroendocrinol Lett 23:303–308
83. Lorber A, Gazit A Z, Khoury A, Schwartz Y, Mandel H (2003) Cardiac manifestations in thiamine-responsive megaloblastic anemia syndrome. Pediatr Cardiol 24:476–481
84. Makarchikov AE, Lakaye B, Gulyai IE, Czerniecki J, Coumans B, Wins P et al. (2003) Thiamine triphosphatase and thiamine triphophatase activities: from bacteria to mammals. Cell Mol Life Sci 60:1477–1488
85. Markannen T, Kalliomaki JL (1966) Transketolase activity of blood cells in various clinical conditions. Am J Med Sci 252:564–569
86. Markson LM, Edwin EE, Lewis G, Richardson C (1974) The production of cerebrocortical necrosis in ruminant calves by the intraruminal administration of amprolium. Br Vet J 130:9–16
87. Mastrogiacoma P, Bettendorff L, Grisar T, Kish SJ (1996) Brain thiamine, its phosphate esters and its metabolizing enzymes in Alzheimer’s disease. Ann Neurol 39:585–591
88. Matsui K, Hakahara H, Watanabe J, Tamatsu H, Nakayawa M et al (1985) Inhibition by thiamine tetrahydrofurfuryl disulfide (TTFD) of the arachidonic acid cascade-line activation as evidenced in the heart-lung preparation of the dog. Jpn J Pharmacol 39:375–379
89. McCandless DW (1982) Energy metabolism in the lateral vestibular nucleus in pyrithiamin-induced thiamin deficiency. In: Sable HZ, Guhbler CJ (eds) Thiamin: twenty years of progress. Ann N Y Acad Sci 378: 355–364
90. McIntyre N, Stanley NN (1971) Cardiac beriberi: two modes of presentation. Br Med J 3:567–569
91. Meador KJ, Loring D, Nichols M, Zamrini E, Rivner M, Posas H et al (1993a) Preliminary findings of high dose thiamine in dementia of Alzheimer’s type. J Geriatr Psychiatry Neurol 6:222–229
92. Meador KJ, Nichols ME, Franke P, Durkin MW, Oberzin RL, Moore LE et al (1993b) Evidence for a central cholinergic effect of high dose thiamin. Ann Neurol 34:724–726
93. Mimori Y, Katsuoka H, Nakamura S (1996) Thiamine therapy in Alzheimer’s disease. Metab Brain Dis 11(1):89–94
94. Minz B (1938) Sur la liberation de la vitamin par le tronc isole de nerf pheumogastrique soumis a la excitation electrique. C.R. Soc Biol (Paris) 127:1251–1253
95. Murata K (1965) Thiaminase. In: Shimazono N, Katsura E (eds) Beriberi and thiamine. Igaku Shoin Ltd., Tokyo, pp 220–254
96. Nabokina SM, Said HM (2004) Characterization of the 5′-regulating region of the human thiamin transporter SLC19A3: In vitro and in vivo studies. Am J Physiol Gastrointest Liver Physiol 287:G822–G829
97. Nishimune T, Watanabl Y, Okazaki H, Akai H (2000) Thiamin is decomposed due to Anaphe spp. Entomophagy in seasonal ataxia patients in Nigeria. J Nutr 130:1625–1628
98. Oishi K, Barchi M, Au AC, Gelb BD, Diaz GA (2004) Male infertility due to germ cell apoptosis in mice lacking the thiamin carrier Tht1. A new insight into the critical role of thiamin in spermatogenesis. Dev Biol 266:299–309
99. Ozdemir MA, Alcakus M, Kuroglu, Gunes T, Torun YA (2002) TRMA syndrome (thiamine-responsive megaloblastic anemia): a case report and review of the literature. Pediatr Diab 3:205–209
100. Pang JA, Yardumian A, Davies R, Patterson DL (1986) Shoshin beriberi an underdiagnosed condition? Intensive Care Med 12(5):380–382
101. Peters RA (1936) The biochemical lesion in vitamin B1 deficiency. Lancet 1:1162–1165
102. Platt BS (1967) Thiamine deficiency in human beriberi and in Wernicke’s encephalopathy. In: Wolstenholme GEW, O’Connor M (eds) Thiamine deficiency. Little Brown and Company, Boston, pp 135–143
103. Rogers LE, Porter FS, Sidbury JB (1969) Thiamine-responsive megaloblastic anemia. Pediat 74:494–504
104. Sable HZ, Gubler CJ (eds) (1982) Thiamin: twenty years of progress. Ann NY Acad Sci 378:355–364
105. Schauss A (1981) Diet, crime and delinquency. Berkeley, CA, pp 1–108
106. Scriver CR, Mackenzie S, Clow CL, Delvin E (1971) Thiamine-responsive maple-syrup urine disease. Lancet i:310–312
107. Seligman H, Halkin H, Rauchfleisch S et al (1991) Thiamine deficiency in patients with congestive heart failure receiving long-term furosemide therapy: a pilot study. Am J Med 91:151–155
108. Shreeve JE, Edwin EE (1974) Thiaminase-producing strains of Cl. Sporogenes associated with outbreaks of cerebrocortical necrosis. Vet Rec 94(15):330
109. Stepuro AL, Piletskaya TO, Stepura II (2005) Role of thiamine thiol forms in nitric oxide metabolism. Biochemistry (Mosc) 70:339–349
110. Thornalley PJ (2003) Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine. Diabetes 57:2110–2120
111. Wells DG, Baylis EM, Holoway L, Marks V (1968) Erythrocyte-transketolase activity in megaloblastic anaemia. Lancet ii:543–545
112. Williams RR (1938) Chemistry of thiamine (Vitamin B1). JAMA 110:727–731
113. Williams RD, Mason HL, Marschelle HP, Russell MW (1943) Induced thiamine (Vitamin B1) deficiency in man. Arch Int Med 71:38–53
114. Yui Y, Fujiwara H, Mitsui H et al (1978) Furosemide-induced thiamine deficiency (abstract). Jpn Circ J 4:744
115. Zbinden G (1962) Therapeutic use of vitamin B1 in diseases other than beriberi. Ann NY Acad Sci 98:550–561